Prof Paul Neeson
Honorary Conjoint Professorial Fellow
The Sir Peter MacCallum Department of Oncology
223 Scholarly works
13 Projects
HIGHLIGHTS
2026
Journal article
[177Lu]Lu-PSMA-617 in combination with pembrolizumab for treatment of metastatic castration resistant prostate cancer (PRINCE): a single-arm, phase 1b/2 study
DOI: 10.1016/S1470-2045(26)00017-32026
Journal article
P0350 Biochemical recurrence and safety in patients with high-risk localised prostate cancer treated with [177Lu] Lu-PSMA-617 prior to prostatectomy: Follow-up of the LuTectomy trial
DOI: 10.1016/s0302-2838(26)01246-72026
Journal article
Metastasis-directed therapy with or without pembrolizumab for oligometastatic clear cell renal cell carcinoma: Pooled analysis of two prospective single-arm phase II trials.
DOI: 10.1200/jco.2026.44.7_suppl.4982026
Journal article
Parity and lactation induce T-cell-mediated breast cancer protection
DOI: 10.1038/s41586-025-09713-52021
Research grants (international)
Identifying Genetic, Transcriptional and Microenvironment Drivers of Lethal Prostate Cancer for Better Patient Stratification, Disease Tracking and Drug Target Discovery
2017
Research grants (other domestic)
Novel Approaches for Overcoming Resistance to Therapies for Advanced Melanoma
2017
Research Grant
Combination of Radionuclide 177lu-Psma Therapy With Pembrolizumab in Patients With Metastatic Castration-Resistant Prostate Cancer (Mcrpc)
RECENT SCHOLARLY WORKS
2026
Journal article
Metastasis-directed Therapy With or Without Pembrolizumab for Oligometastatic Clear Cell Renal Cell Carcinoma: Pooled Analysis of Two Prospective Single-arm Phase 2 Trials
DOI: 10.1016/j.eururo.2026.03.0242026
Journal article
Bispecific antibody combination therapies in diffuse large B-cell lymphoma
DOI: 10.1111/bjh.702282025
Conference Proceedings
Development of a novel CAR-T cell therapy using a multimodal approach to target T cell lymphoma
DOI: 10.1182/blood-2025-41122025
Conference Proceedings
DLBCL tumor microenvironment archetype and CD4 T cell conversion to cytotoxic cells are required for response to glofitamab
DOI: 10.1182/blood-2025-5572025
Conference Proceedings
Integrative analysis of the tumour immune microenvironment of breast implant-associated anaplastic large cell lymphoma using multi-omics
DOI: 10.1182/blood-2025-35632025
Journal article
Personalized Immunotherapy for T Cell Lymphomas: From Immune Escape to Precision Therapeutics
DOI: 10.3390/jpm15110560
RECENT PROJECTS
2024
Research grants (other domestic)
New Frontiers for CAR T Cell Therapy in Breast Cancer
2026
Research grants (other domestic)
Generating Early Phenotype CAR-T for Treatment of Osteosarcoma in Dogs